Butyric acid in bowel inflammations;Kwas masłowy w zapaleniach jelit

Przeglad Gastroenterologiczny

Volumn 5, Issue 5, 2010, Pages 251-257

  Banasiewicz, Tomasz ^a   Borycka Kiciak, Katarzyna ^b   Kiciak, Adam ^b   Kotunia, Anna ^c   Pietrzak, Piotr ^c   Zabielski, Romuald ^c   Krokowicz, Piotr ^d  

^a Uniwersytetu Medycznego   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^d Katedra i Klinika Chirurgii Ogolnej i Kolorektalnej   (Poland)

Author keywords

Diarrhoea; Diversion colitis; Radiation colitis; Sodium butyrate; Ulcerative colitis

Indexed keywords

BUTYRIC ACID; VOLATILE AGENT;

CHEMOTHERAPY; COLITIS; ENTERITIS; ENTEROPATHY; INTESTINE; INTESTINE MUCOSA; PHYSICAL CHEMISTRY; REVIEW; ULCERATIVE COLITIS;

EID: 78649716569     PISSN: 18955770     EISSN: None     Source Type: Journal    
DOI: 10.5114/pg.2010.17261     Document Type: Review

References (45)

1. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793-8.
2. Perrine SP, Hermine O, Small T, et al. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood 2007; 109: 2571-8.
3. Kotunia A, Pietrzak P, Guilloteau P, et al. Kwas masłowy w przewodzie pokarmowym. Przegl Gastroenterol 2010; 5: 1-6.
4. Jeppesen PB, Mortensen PB. Enhancing bowel adaptation in short bowel syndrome. Curr Gastroenterol Rep 2002; 4: 338-47.
5. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 2002; 37: 67-72.
6. Galvez J, Rodrigez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005; 49: 601-8.
7. Welters CF, Heineman E, Thunnissen FB, et al. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 2002; 45: 621-7.
8. De Preter V, Bulteel V, Suenaert P, et al. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa. Inflamm Bowel Dis 2009; 15: 335-40.
9. Ma CK, Gottlieb C, Haas PA. Diversion colitis: a clinico - athological study of 21 case. Hum Pathol 1990; 21: 429-36.
10. Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989; 320: 23-8.
11. Wachtershauser A, Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 2000; 39: 164-71.
12. Mortensen FV, Hessov I, Brike H, et al. Microcirculatory and trophic effects of short-chain fatty acids in the human rectum after Hartmann's procedure. Br J Surg 1991; 78: 1208-11.
13. Guillemot F, Colombel JF, Neut C, et al. Treatment of diversion colitis by short-chain fatty acids. Dis Colon Rectum 1991; 34: 861-4.
14. Schouten WR, Duisters MM, Briel JW, et al. Short-chain fatty acids irrigation in the treatment of proctitis in excluded rectal segments. Falk Symposium NO 73, Strasbourg, September 8-10, 1993; Abstract D5.
15. Schauber J, Bark T, Jaramillo E, et al. Local short-chain fatty acid supplementation without beneficial effects on inflammation in excluded rectum. Scand J Gastroenterol 2000; 35: 184-9.
16. Chapman MA, Grahn MF, Boyle MA, et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994; 35: 73-6.
17. Allan ES, Winter S, Light AM, et al. Mucosal enzyme activity for butyrate oxidation: no defect in patients with ulcerative colitis. Gut 1996; 38: 886-93.
18. Vernia P, Caprilli R, Latella G, et al. Fecal lactate and ulcerative colitis. Gastroenterology 1988; 95: 1564-8.
19. Holtug K, Hove H, Mortensen PB. Stimulation of butyrate absorption in the human rectum in vivo. Scand J Gastroenterol 1995; 30: 982-8.
20. Tobisawa Y, Imai Y, Fukuda M, et al. Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice. J Biol Chem 2010; 285: 6750-60.
21. Steinhar AH, Brzeziński A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enema. Am J Gastroenterol 1994; 89: 179-83.
22. Vernia P, Marcheggiano A, Caprilli R, et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 309-13.
23. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with shortchain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci 1991; 36: 185-7.
24. Breuer RI, Soergel KH, Lashner BA, et al. Short-chain fatty acid rectal irrigation for left-side ulcerativecolitis: a randomized, placebo-controlled trial. Gastroenterology 1996; 110: 873.
25. Senagore AJ, MacKeigan JM, Scheider M, et al. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992; 35: 923-7.
26. Scheppach W, Richter F, Boxberger F, et al. Effects of short-chain fatty acids on mucosal hyperproliferation in ulcerative colitis. Gastroenterology 1996; 110: 589.
27. Vernia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003; 3: 244-8.
28. Luhrs H, Gerke T, Muller JG, et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002; 37: 458-66.
29. Hallert C, Bjorck I, Nyman M, et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9: 116-21.
30. Zhang HQ, Ding TT, Zhao JS, et al. Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J Gastroenterol 2009; 15: 1821-8.
31. Koruda MJ, Rolandelli RH, Bliss DZ, et al. Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats. Am J Clin Nutr 1990; 51: 685-9.
32. Pinto A, Fidalgo P, Cravo M, et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum 1999; 42: 788-95; discussion 795-6.
33. Al-Sabbagh R, Sinicrope F, Sellin J, et al. Short-chain fatty acid (SCFA) enemas for radiation colitis. Gastroenterology 1994; 106: A2.
34. Mamel JJ, Chen M, Combs W, et al. Short-chain fatty acid (SCFA) enema are useful for treatment of chronic radiation proctitis (CRP). Gastroenterolgy 1995; 108: A305.
35. Vernia P, Casale V, Fracasso PL, et al. Preliminary results of a randomized trial with topical sodium butyrate enemas in acute radiation proctitis (CRP). Gastroenterolgy 1996; 110: A1039.
36. Holtug K, Rasmussen HS. Mortensen PB. An in vitro study of short-chain fatty acid concentrations, production and absorption in pig (Sus Scrofa) colon. Comp Biochem Physiol 1992; 103: 189-97.
37. Rabbani GH, Albert MJ, Rahman H, et al. Short-chain fatty acids inhibit fluid and electrolyte loss induced by cholera toxin in proximal colon of rabbit in vivo. Dig Dis Sci 1999; 44: 1547-53.
38. Schneider SM, Girard-Popau F, Filippi J. Effects of Sacharomyces boulardi on faecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 2005; 11: 6165-9.
39. Lionetti P, Callegari ML, Ferrari S. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29: 173-5.
40. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42: 1203-6.
41. Clausen MR, Bonnen H, Tvede M, et al. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 1991; 101: 1497-504.
42. May T, Mackie RI, Fahey GC, et al. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol 1994; 19: 916-22.
43. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-9.
44. Canani RB, Terrin G, Cirillo PIA, et al. Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology 2004; 127: 630-4.
45. Claus R, Günthner D, Letzguss H. Effects of feeding fat-coated butyrate on mucosal morphology and function in the small intestine of the pig. J Anim Physiol Anim Nutr 2007; 91: 312-8.